论文信息 - Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations: A retrospective multicenter study. - 字舞流文

Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations: A retrospective multicenter study.

J. Neal | H. Wakelee | J. Riess | S. Stewart | C. Blakely | J. Chen | G. Oxnard | M. Gubens | H. Husain | C. McCoach | J. Rotow | Z. Piotrowska | J. Aredo | L. Huppert | Jingran Ji | Melisa L. Wong | A. Piper-Vallillo | R. Cobb